Subgroup analyses showed that using whole flaxseed in doses ≥30 g d-1 , longer-term interventions ( ≥12 weeks ) and studies including participants with higher BMI ( ≥ 27 kg m-2 ) had positive effects on body composition  .
Whole flaxseed is a good choice for weight management particularly for weight reduction in overweight and obese participants
Flaxseed consumption may be inversely associated with obesity ; however , findings of available r and omized controlled trials ( RCTs ) are conflicting .
The present study aim ed to systematic ally review and analyse RCTs assessing the effects of flaxseed consumption on body weight and body composition .
Effects of flaxseed consumption on systemic inflammation and serum lipid profile in hemodialysis patients with lipid abnormalities
Inflammation and lipid abnormalities are two important risk factors for cardiovascular disease in hemodialysis ( HD ) patients . The present study was design ed to investigate the effects of flaxseed consumption on systemic inflammation and serum lipid profile in HD patients with lipid abnormalities . This was an unblinded , r and omized clinical trial . Thirty HD patients with dyslipidemia ( triglyceride > 200 mg/dL and /or high‐density lipoprotein‐cholesterol ( HDL‐C ) < 40 mg/dL ) were r and omly assigned to either a flaxseed or control group . Patients in the flaxseed group received 40 g/day ground flaxseed for 8 weeks , whereas patients in the control group received their usual diet , without any flaxseed . At baseline and at the end of week 8 , 7 mL of blood was collected after a 12‐ to 14‐hour fast and serum concentrations of triglyceride , total cholesterol , low‐density lipoprotein‐cholesterol ( LDL‐C ) , HDL‐C , and C‐reactive protein ( CRP ) were measured . Serum concentrations of triglyceride ( P < 0.01 ) , total cholesterol ( P < 0.01 ) , LDL‐C ( P < 0.01 ) , and CRP ( P < 0.05 ) decreased significantly in the flaxseed group at the end of week 8 compared with baseline , whereas serum HDL‐C showed a significant increase ( P < 0.01 ) . These changes in the flaxseed group were significant in comparison with the control group . The study indicates that flaxseed consumption improves lipid abnormalities and reduces systemic inflammation in HD patients with lipid abnormalities
Subgroup analyses showed that using whole flaxseed in doses ≥30 g d-1 , longer-term interventions ( ≥12 weeks ) and studies including participants with higher BMI ( ≥ 27 kg m-2 ) had positive effects on body composition  .
Whole flaxseed is a good choice for weight management particularly for weight reduction in overweight and obese participants
Flaxseed consumption may be inversely associated with obesity ; however , findings of available r and omized controlled trials ( RCTs ) are conflicting .
The present study aim ed to systematic ally review and analyse RCTs assessing the effects of flaxseed consumption on body weight and body composition .